Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShort-Term Debt repayments
Ratios

Kiora Pharmaceuticals (KPRX) Receivables - Other (2016 - 2018)

Kiora Pharmaceuticals' Receivables - Other history spans 4 years, with the latest figure at $922488.0 for Q1 2018.

  • For Q1 2018, Receivables - Other rose 739.89% year-over-year to $922488.0; the TTM value through Mar 2018 reached $922488.0, up 739.89%, while the annual FY2016 figure was $37349.0, 95.88% down from the prior year.
  • Receivables - Other reached $922488.0 in Q1 2018 per KPRX's latest filing, up from $602000.0 in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $922488.0 in Q1 2018 to a low of $37349.0 in Q4 2016.
  • Average Receivables - Other over 4 years is $349564.9, with a median of $146078.0 recorded in 2017.
  • Peak YoY movement for Receivables - Other: crashed 95.88% in 2016, then surged 1511.78% in 2017.
  • A 4-year view of Receivables - Other shows it stood at $907500.0 in 2015, then plummeted by 95.88% to $37349.0 in 2016, then skyrocketed by 1511.82% to $602000.0 in 2017, then surged by 53.24% to $922488.0 in 2018.
  • Per Business Quant, the three most recent readings for KPRX's Receivables - Other are $922488.0 (Q1 2018), $602000.0 (Q3 2017), and $146078.0 (Q2 2017).